Promed Bioscience secures over €1 million growth financing led by KV Fund II
Promed Bioscience, a biotech company specializing in advanced collagen-based biomaterials for regenerative medicine, has successfully closed a €1.25 million growth financing round led by KV Fund II.
Overall, the investment emphasises ...